(Q33424988)

26 July 2017

title

Mycophenolate mofetil therapy for severe immune thrombocytopenia (English)

1 reference

26 July 2017

1 reference

9

Roberto Stasi

1 reference

26 July 2017

10

Marie Scully

1 reference

26 July 2017

Alice Taylor

1

1 reference

26 July 2017

Lucy Neave

2

1 reference

26 July 2017

Shalini Solanki

3

1 reference

26 July 2017

John Paul Westwood

4

1 reference

26 July 2017

Ilaria Terrinonive

5

1 reference

26 July 2017

Siobhan McGuckin

6

1 reference

26 July 2017

Jaimal Kothari

7

1 reference

26 July 2017

Nichola Cooper

8

1 reference

26 July 2017

language of work or name

English

0 references

publication date

6 August 2015

1 reference

British Journal of Haematology

26 July 2017

published in

1 reference

26 July 2017

volume

171

1 reference

26 July 2017

issue

4

1 reference

26 July 2017

page(s)

625-630

1 reference

Current strategies and future trends in immunosuppression after heart transplantation

26 July 2017

cites work

1 reference

Combination immunosuppressant therapy for patients with chronic refractory immune thrombocytopenic purpura

21 January 2018

1 reference

Thymic retention of CD4+CD25+FoxP3+ T regulatory cells is associated with their peripheral deficiency and thrombocytopenia in a murine model of immune thrombocytopenia

21 January 2018

1 reference

Calcineurin inhibitors in liver transplantation - still champions or threatened by serious competitors?

21 January 2018

1 reference

A murine model of severe immune thrombocytopenia is induced by antibody- and CD8+ T cell-mediated responses that are differentially sensitive to therapy

21 January 2018

1 reference

How I treat idiopathic thrombocytopenic purpura (ITP).

21 January 2018

1 reference

Mycophenolate mophetil therapy for chronic immune thrombocytopenic purpura resistant to steroids, immunosuppressants, and/or splenectomy in adults

21 January 2018

1 reference

Mycophenolate mofetil in the treatment of systemic lupus erythematosus

21 January 2018

1 reference

Should mycophenolate mofetil replace cyclophosphamide as first-line therapy for severe lupus nephritis?

21 January 2018

1 reference

Mycophenolate mofetil for the treatment of refractory auto-immune haemolytic anaemia and auto-immune thrombocytopenia purpura

21 January 2018

1 reference

Efficacy of mycophenolate mofetil in adult refractory auto-immune cytopenias: a single center preliminary study

21 January 2018

1 reference

Suppression of in vitro megakaryocyte production by antiplatelet autoantibodies from adult patients with chronic ITP

21 January 2018

1 reference

Efficacy of mycophenolate mofetil as single-agent therapy for refractory immune thrombocytopenic purpura

21 January 2018

1 reference

International consensus report on the investigation and management of primary immune thrombocytopenia

21 January 2018

1 reference

Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group

21 January 2018

1 reference

ITP: a historical perspective

21 January 2018

1 reference

Response to B-cell depleting therapy with rituximab reverts the abnormalities of T-cell subsets in patients with idiopathic thrombocytopenic purpura

21 January 2018

1 reference

Analysis of regulatory T-cell changes in patients with idiopathic thrombocytopenic purpura receiving B cell-depleting therapy with rituximab

21 January 2018

1 reference

Controlled-dose versus fixed-dose mycophenolate mofetil for kidney transplant recipients: a systematic review and meta-analysis of randomized controlled trials

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/BJH.13622

1 reference

release_3jynvqrpk5eqhhjf5uiw7iya4y

26 July 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/3jynvqrpk5eqhhjf5uiw7iya4y

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference